A Phase I/II Study of Lenalidomide and Obinutuzumab With CHOP for Diffuse Large B Cell Lymphoma
Clinical trial NCT02529852 · COMPLETED
Trial details
- NCT number
- NCT02529852
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-04
- Primary completion
- 2022-10-31
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.